Opportunities for Intervention in the Week Preceding a Sepsis Hospitalization

Opportunities for Intervention in the Week Preceding a Sepsis Hospitalization

Product not yet rated

Recorded On: 08/31/2022

Description: 

This session will review patient encounters with the healthcare system in the week preceding a sepsis hospitalization. Encounters in the seven days prior to a sepsis admission often present valuable opportunities for intervention and for preventing the transition from infection to sepsis. Learners will review data on the frequency and types of encounters common ahead of a sepsis admission, discuss whether these high-risk patients can be identified during these encounters, and discover advances in care and screening with the potential to prevent sepsis hospitalization or identify decompensation earlier.

Learning Objectives: 

At the end of the activity, the learner should be able to:

  • Identify the characteristics of patients who have an encounter with the healthcare system in the week preceding a sepsis hospitalization;
  • Examine possible interventions for preventing the development, or lessening the severity, of sepsis in this patient population.

Target Audience: 

Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.

Alexander H. Flannery, Pharm.D., Ph.D., FCCM, FCCP, FASHP, BCCCP, BCPS

Assistant Professor, Department of Pharmacy Practice and Science

University of Kentucky College of Pharmacy

Alexander Flannery, Pharm.D., Ph.D., FCCM, FCCP, FASHP, BCCCP, BCPS, received his Doctor of Pharmacy degree from the University of Kentucky, followed by completion of a PGY1 pharmacy practice residency at the Medical University of South Carolina and a PGY2 critical care specialty residency at the University of Kentucky.

Dr. Flannery's clinical and translational research program focuses on sepsis and acute kidney injury with an emphasis on biologic and molecular observations from human disease, to gain a better understanding of the underlying pathophysiology. He works collaboratively to develop improved pre-clinical and clinical approaches to treatment based on this information.

Dr. Flannery coordinates Evidence-Based Medicine and Clinical Reasoning courses, among other teaching activities at the University of Kentucky College of Pharmacy. He maintains an active practice site in the Medical Intensive Care Unit at UK HealthCare. He is an active member of the American College of Clinical Pharmacy and the Society of Critical Care Medicine, where he is recognized as a Fellow in the American College of Critical Care Medicine.

Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 1.0 contact hours.

Other healthcare professionals will receive a certificate of attendance for 1.0 contact hours.

Medical Disclaimer

The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.

Components visible upon registration.